|
|
Neurology July 2009
Volume 73
Issue 3
| This week in Neurology(R) |
this week in neurology(r): highlights of the july 21 issue.
Pages: 167
|
| Editorials |
preventive neurology: on the way from knowledge to action.
- Kivipelto, Miia, MD, PhD, Solomon, Alina. Pages: 168-169
|
the vectors study: when too much of a good thing is harmful.
- Cramer, Steven. Pages: 170-171
|
| In Memoriam |
joseph a. resch, md, faan (1914-2009).
- Kennedy, William. Pages: 172
|
| Articles |
predicting risk of dementia in older adults: the late-life dementia risk index.
- Barnes, D, PhD, MPH, Covinsky, K, MD, MPH, Whitmer, R, Kuller, L, MD, DrPH, Lopez, O, Yaffe, K. Pages: 173-179
>
Show/Hide Abstract
Objective: To develop a late-life dementia risk index that can accurately stratify older adults into those with a low, moderate, or high risk of developing dementia within 6 years.Methods: Subjects were 3,375 participants in the Cardiovascular Health Cognition Study without evidence of dementia at baseline. We used logistic regression to identify those factors most predictive of developing incident dementia within 6 years and developed a point system based on the logistic regression coefficients.Results: Subjects had a mean age of 76 years at baseline; 59% were women and 15% were African American. Fourteen percent (n = 480) developed dementia within 6 years. The final late-life dementia risk index included older age (1-2 points), poor cognitive test performance (2-4 points), body mass index <18.5 (2 points), >=1 apolipoprotein E [varepsilon]4 alleles (1 point), cerebral MRI findings of white matter disease (1 point) or ventricular enlargement (1 point), internal carotid artery thickening on ultrasound (1 point), history of bypass surgery (1 point), slow physical performance (1 point), and lack of alcohol consumption (1 point) (c statistic, 0.81; 95% confidence interval, 0.79-0.83). Four percent of subjects with low scores developed dementia over 6 years compared with 23% of subjects with moderate scores and 56% of subjects with high scores.Conclusions: The late-life dementia risk index accurately stratified older adults into those with low, moderate, and high risk of developing dementia. This tool could be used in clinical or research settings to target prevention and intervention strategies toward high-risk individuals.(C)2009AAN Enterprises, Inc.
|
iv immunoglobulin is associated with a reduced risk of alzheimer disease and related disorders.
- Fillit, H, Hess, G, Hill, J, Bonnet, P, Toso, C. Pages: 180-185
>
Show/Hide Abstract
Objective: To compare the incidence of Alzheimer disease and related disorders (ADRD) in patients treated with IV immunoglobulin (IVIg) for non-Alzheimer disease (AD) indications vs untreated controls.Methods: This retrospective case-control analysis used medical claims for patients >=65 years old from a national database of 20 million age-qualified patients. Cases received >=1 IVIg administration during April 1, 2001-August 31, 2004, had claims 1 year prior to first (index) IVIg administration to confirm absence of pre-index ADRD, and had >=3 years of continuous claims post-index. Untreated controls had their first medical claim during April 1, 2000-August 31, 2004, and otherwise met the same requirements as cases. Controls were matched 100:1 to cases on age, gender, and risk factors for ADRD. The relative incidence of ADRD post-index for the IVIg-treated cases vs untreated controls was estimated using Kaplan-Meier survival curves and a Cox proportional hazards model.Results: Treated patients in the Kaplan-Meier analysis had lower ADRD incidence (p = 0.02) with an estimated 2.6% of the 847 IVIg-treated vs 4.6% of 84,700 controls diagnosed with ADRD at 60 months after index date. Treated patients in the Cox proportional hazard model had a 42% lower risk of being diagnosed with ADRD (hazard ratio, 0.577; 95% confidence interval, 0.359 to 0.930; p = 0.024) with an estimated 2.8% of treated vs 4.8% of controls diagnosed with ADRD at 60 months after index date.Conclusions: Previous treatment with IV immunoglobulin was associated with a reduced risk of developing Alzheimer disease and related disorders (ADRD) in this study. Evidence from additional studies is needed to evaluate the relationship between IVIg exposure and ADRD diagnosis.(C)2009AAN Enterprises, Inc.
|
lifespan influences on mid- to late-life cognitive function in a chinese birth cohort.
- Zhang, Z, Plassman, B, Xu, Q, Zahner, G, Wu, B, Gai, M, Wen, H, Chen, X, Gao, S, Hu, D, Xiao, X, Shen, Y, Liu, A, Xu, T. Pages: 186-194
>
Show/Hide Abstract
Objective: To explore factors throughout the lifespan that influence cognition in midlife to late life.Methods: We conducted a retrospective birth cohort study of 2,062 individuals born during 1921-1954 in Beijing, China. In 2003-2005, birth records were abstracted, and participants then 50-82 years old received standardized examinations for health, cognition, and socio-environmental measures. Using cumulative logit models, we assessed adjusted relative effects of prenatal, early life, and adult factors on mid- to late-life cognition.Results: Most prenatal factors were associated with mid- to late-life cognition in the unadjusted models. However, when childhood and adult factors were sequentially added to the models, the impact of prenatal factors showed successive attenuation in effect size, and became insignificant. In contrast, early life factors remained significantly associated with mid- to late-life cognition even after full life-course adjustments. Specifically, those whose fathers had laborer vs professional occupations (odds ratio [OR]Laborer 1.74; 95% confidence interval [CI]: 1.25-2.42) had poorer cognitive outcomes, while individuals who drank milk daily in childhood (OR 0.65; 95% CI: 0.54-0.80), had more years of education (OR10-12 years 0.60; 95% CI: 0.45-0.81; OR13+ yrs 0.29; 95% CI: 0.23-0.38), and were taller adults (ORheight >= SD 0.65; 95% CI: 0.49-0.86) had better cognition. The high prenatal risk infants had similar patterns with a trend toward a stronger association between cognition and socioenvironmental factors.Conclusion: Mid- to late-life cognition is influenced by factors over the entire lifespan with the greatest impact coming from early life exposures. Nutrition, education, social, and family environment in early life may have a long-term impact on cognition in developing countries.(C)2009AAN Enterprises, Inc.
|
very early constraint-induced movement during stroke rehabilitation (vectors): a single-center rct.
- Dromerick, A, Lang, C, Birkenmeier, R, MS, OTR, Wagner, J, Miller, J, Videen, T, Powers, W, Wolf, S, Edwards, D. Pages: 195-201
>
Show/Hide Abstract
Background: Constraint-induced movement therapy (CIMT) is among the most developed training approaches for motor restoration of the upper extremity (UE).Methods: Very Early Constraint-Induced Movement during Stroke Rehabilitation (VECTORS) was a single-blind phase II trial of CIMT during acute inpatient rehabilitation comparing traditional UE therapy with dose-matched and high-intensity CIMT protocols. Participants were adaptively randomized on rehabilitation admission, and received 2 weeks of study-related treatments. The primary endpoint was the total Action Research Arm Test (ARAT) score on the more affected side at 90 days after stroke onset. A mixed model analysis was performed.Results: A total of 52 participants (mean age 63.9 +/- 14 years) were randomized 9.65 +/- 4.5 days after onset. Mean NIHSS was 5.3 +/- 1.8; mean total ARAT score was 22.5 +/- 15.6; 77% had ischemic stroke. Groups were equivalent at baseline on all randomization variables. As expected, all groups improved with time on the total ARAT score. There was a significant time x group interaction (F = 3.1, p < 0.01), such that the high intensity CIT group had significantly less improvement at day 90. No significant differences were found between the dose-matched CIMT and control groups at day 90. MRI of a subsample showed no evidence of activity-dependent lesion enlargement.Conclusion: Constraint-induced movement therapy (CIMT) was equally as effective but not superior to an equal dose of traditional therapy during inpatient stroke rehabilitation. Higher intensity CIMT resulted in less motor improvement at 90 days, indicating an inverse dose-response relationship. Motor intervention trials should control for dose, and higher doses of motor training cannot be assumed to be more beneficial, particularly early after stroke.(C)2009AAN Enterprises, Inc.
|
superficial siderosis in the general population.
- Vernooij, M, MD, PhD, Ikram, M, MD, PhD, Hofman, A, MD, PhD, Krestin, G, MD, PhD, Breteler, M, MD, PhD, van der Lugt, A, MD, PhD. Pages: 202-205
>
Show/Hide Abstract
Background: Superficial siderosis is a rare radiologic diagnosis of hemosiderin deposition in subpial brain layers. In case studies, an association between superficial siderosis and cerebral amyloid angiopathy (CAA) has been described. Also, a potential role of superficial siderosis in Alzheimer disease (AD) was hypothesized. All previously reported cases of superficial siderosis were detected because of overt clinical symptoms. We studied the occurrence of superficial siderosis on brain MRI in a general population of nondemented elderly.Methods: In 1,062 persons (mean age 69.6 years) from the population-based Rotterdam Scan Study, we performed T2*-weighted MRI to assess the presence of superficial siderosis. Furthermore, the presence, number, and location of cerebral microbleeds were rated, as lobar microbleeds are thought to be indicative of CAA.Results: We found that superficial siderosis was present in 7 (0.7%) individuals, all of whom had cerebral microbleeds in lobar locations. Furthermore, in all 7 persons, microbleeds were located in close vicinity to superficial siderosis.Conclusions: Our results provide further indirect support for the presumed link between superficial siderosis and cerebral amyloid angiopathy (CAA). Whether superficial siderosis may be a marker for severity or worse prognosis of CAA needs to be further evaluated in longitudinal follow-up.(C)2009AAN Enterprises, Inc.
|
course in parkinson disease subtypes: a 39-year clinicopathologic study .
- Rajput, A, Voll, A, Rajput, M, Robinson, C, Rajput, A. Pages: 206-212
>
Show/Hide Abstract
Background: Individual variations in the course of Lewy body Parkinson disease (PD) are well known. Patients have been classified into different clinical subtypes to identify differences in the course among the subgroups. Several studies indicate that the outcome is more favorable in tremor dominant (TD) cases but others report no difference. A majority of progression studies are based on cross-sectional single point data or short-term clinical observations. The lack of longitudinally followed autopsy-confirmed PD cohort remains a major weakness in the literature. Biochemical studies of brain indicate most pronounced abnormalities in akinetic/rigid (AR) and the least in TD cases. We postulate that PD course in these subtypes is concordant with the biochemical findings.Objective: To compare the course in TD, mixed (MX), and AR subtypes of PD.Methods: Longitudinal clinical follow-up and autopsy studies were performed on 166 patients with PD over 39 years (1968-2006). Patients were classified into TD, AR, and MX based on the entire clinical course. Only the pathologically confirmed PD cases were included.Results: Sixty-six percent of cases had MX, 26% AR, and 8% TD profile. The age at onset was younger (p < 0.001) and progression to Hoehn & Yahr stage 4 was slower (p = 0.016) in the TD cases. Dementia was most common in AR (p = 0.039) and the least common in TD. In general, the course was most favorable in TD, followed by MX and AR subgroups.Conclusion: The three subtypes of Parkinson disease have different courses which are concordant with the differences in brain biochemical abnormalities.(C)2009AAN Enterprises, Inc.
|
selegiline shortage: causes and costs of a generic drug shortage.
- Dorsey, E, MD, MBA, Thompson, J, Dayoub, E, George, B, Saubermann, L, PharmD, BCPS, Holloway, R, MD, MPH. Pages: 213-217
>
Show/Hide Abstract
Background: In September 2007, shortages of generic selegiline occurred, forcing patients to either switch to more expensive alternatives or forego treatment. We sought to evaluate prescription trends of generic selegiline and to quantify the economic impact of any resulting drug substitution of more expensive alternatives.Methods: We analyzed proprietary data from IMS Health on monthly prescriptions in the United States for selegiline and potential substitutes from February 2002 through December 2007. Linear regression was used to predict the number of expected prescriptions after August 2007 had a shortage not occurred. The main outcome measures were the changes in prescriptions filled and the economic impact of drug substitution.Results: Prior to the shortage, total prescriptions filled for generic selegiline decreased 42%, and supply consolidated into one company, Apotex Inc., Toronto, Canada, whose market share increased from 41% to 83%. During the first 4 months of the shortage, Apotex Inc. filled 10,500 fewer prescriptions than projected and other selegiline manufacturers filled 7,400 more than projected for a net shortage of 3,100 prescriptions. The number of branded selegiline capsules filled during this period increased by 1,800 above projections, and 1,300 prescriptions for generic selegiline were not refilled or substituted. The societal cost of substituting generic selegiline with branded capsules was $75,000 over the first 4 months of the shortage.Conclusions: Generic drug shortages carry economic and health implications. Given ongoing consolidation in the generics drug industry, these shortages may become more common and may require heightened regulatory scrutiny of the generic drug industry.(C)2009AAN Enterprises, Inc.
|
why do seizures in generalized epilepsy often occur in the morning?
- Badawy, R, MB, BCh, Macdonell, R, MD, FRACP, Jackson, G, MD, FRACP, Berkovic, S, MD, FRACP. Pages: 218-222
>
Show/Hide Abstract
Objective: We used transcranial magnetic stimulation to investigate the effect of diurnal variability on cortical excitability in patients with epilepsy.Methods: Thirty drug-naive patients with epilepsy (20 idiopathic generalized epilepsy [IGE], including 10 juvenile myoclonic epilepsy [JME], and 10 focal epilepsy) and 10 control subjects without epilepsy were studied both early in the morning and late in the afternoon. We measured the mean motor thresholds and constructed recovery curves at short (2-15 msec) and long (50-400 msec) interstimulus intervals.Results: An increase in cortical excitability indicated by decreased short and long intracortical inhibition was observed early in the morning compared to the afternoon in patients with JME. In other IGE syndromes, there was decreased long intracortical inhibition only. No effect was found in subjects with focal epilepsy or controls without epilepsy.Conclusion: Cortical excitability measured by transcranial magnetic stimulation increases early in the morning in patients with idiopathic generalized epilepsy, particularly in juvenile myoclonic epilepsy, but not in subjects with focal epilepsy or controls without epilepsy. This may explain the increased seizure susceptibility in this cohort at this time of day.(C)2009AAN Enterprises, Inc.
|
laterality and location influence catamenial seizure expression in women with partial epilepsy.
- Quigg, M, MD, MSc, Smithson, S, Fowler, K, Sursal, T, Herzog, A, MD, MSc. Pages: 223-227
>
Show/Hide Abstract
Objective: The temporal distribution of seizures in women with localization-related epilepsy occurs periodically according to a model "clock" with the peak phase of occurrence corresponding to menstrual onset. The location and laterality of the epileptic lesion as well as patient age may affect periodicity.Methods: Baseline data from seizure and menstrual diaries of ~3 months duration were obtained from 100 women enrolled in a trial of hormonal therapy for localization-related epilepsy. Durations of individual cycles were normalized to a common menstrual phase and period. Normalized data were then combined to create distributions evaluated by localization (lobar: temporal [TL], extratemporal [XL], multifocal [MF], unknown), lateralization (left, right, bilateral, unknown), and age. Distributions were evaluated with analysis of variance (ANOVA) and curve-fitted by nonlinear least squares cosinor analysis.Results: A total of 71 patients had TL (left = 25, right = 29, bilateral = 17), 10 XL, 14 MF, and 5 unknown seizure foci. XL and MF seizures occurred randomly across the 28-day cycle. TL seizures (left = 875, right = 706) occurred nonrandomly (ANOVA p = 0.0003) and cyclically with peak occurrence near onset of menses ([value +/- SD] peak = 1.6 +/- 2.3 days, period = 27.0 days). Left-side TL seizures peaked cyclically at onset of menses (ANOVA p = 0.04, peak = 0.0 +/- 3.0 days, period = 30 days); right-side TL seizures occurred randomly. Age did not have a cyclical effect. Women below the median age had a significantly higher seizure rate than those above the median age.Conclusion: Circalunar rhythms of seizures in women, and therefore, possibly strategies of hormonal treatments of catamenial epilepsy, vary with the neuroanatomic substrate of the seizure focus.(C)2009AAN Enterprises, Inc.
|
myasthenic syndrome due to defects in rapsyn: clinical and molecular findings in 39 patients.
- Milone, M, MD, PhD, Shen, X, Selcen, D, Ohno, K, MD, PhD, Brengman, J, Iannaccone, S, Harper, C, Engel, A. Pages: 228-235
>
Show/Hide Abstract
Background: Pathogenic mutations in rapsyn result in endplate acetylcholine receptor (AChR) deficiency and are a common cause of postsynaptic congenital myasthenic syndromes.Methods: Clinical, electrophysiologic, pathologic, and molecular studies were done in 39 patients.Results: In all but one patient, the disease presented in the first 2 years of life. In 9 patients, the myasthenic symptoms included constant or episodic ophthalmoparesis, and 1 patient had a pure limb-girdle phenotype. More than one-half of the patients experienced intermittent exacerbations. Long-term follow-up was available in 25 patients after start of cholinergic therapy: 21 became stable or were improved and 2 of these became asymptomatic; 3 had a progressive course; and 1 died in infancy. In 7 patients who had endplate studies, the average counts of AChR per endplate and the synaptic response to ACh were less reduced than in patients harboring low AChR expressor mutations. Eight patients were homozygous and 23 heterozygous for the common p.N88K mutation. Six mutations, comprising 3 missense mutations, an in-frame deletion, a splice-site mutation, and a nonsense mutation, are novel. Homozygosity for p.N88K was associated with varying grades of severity. No genotype-phenotype correlations were observed except in 8 Near-Eastern patients homozygous for the promoter mutation (c.-38A>G), who had a mild course.Conclusions: All but 1 patient presented early in life and most responded to cholinergic agonists. With early diagnosis and therapy, rapsyn deficiency has a benign course in most patients. There was no consistent phenotype-genotype correlation except for an E-box mutation associated with jaw deformities.(C)2009AAN Enterprises, Inc.
|
| Clinical Implications of Neuroscience Research |
autonomic-mediated immunomodulation and potential clinical relevance.
- Benarroch, Eduardo. Pages: 236-242
|
| Clinical/Scientific Notes |
meis1 p.r272h in familial restless legs syndrome.
- Vilarino-Guell, C, Chai, H, Keeling, B, Young, J, Rajput, A, Lynch, T, Aasly, J, Uitti, R, Wszolek, Z, Farrer, M, Lin, S. Pages: 243-245
|
calcific embolus causing subarachnoid hemorrhage.
- Kranick, Sarah, Levine, Joshua, Cucchiara, Brett. Pages: 245-246
|
| NeuroImages |
mri in amyloid [beta]-related brain angiitis.
- Tschampa, H, Niehusmann, P, Marek, M, Mueller, C, Kuchelmeister, K, MD, PhD, Urbach, H, MD, PhD. Pages: 247
|
| Resident & Fellow Section |
teaching neuroimages: acute bilateral hand weakness from anterior spinal artery territory cord ischemia.
- Balaratnam, Michelle, Pullicino, Patrick. Pages: e13
|
| Correspondence |
effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack.
- Castilla-Guerra, Luis, del Carmen Fernandez-Moreno, Maria, Jimenez-Hernandez, Maria. Pages: 248-249
|
effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack.
- Mascitelli, Luca, Pezzetta, Francesca, Goldstein, Mark. Pages: 249-250
|
| Departments: Calendar |
calendar.
Pages: 251
|
| Future Issues |
in the next issue of neurology(r): volume 73, number 4, july 28, 2009.
Pages: A42
|
|
|